Detection of Bet v1, Bet v2 and Bet v4 specific IgE antibodies in the sera of children and adult patients allergic to birch pollen: Evaluation of different IgE reactivity profiles depending on age and local sensitization

International Archives of Allergy and Immunology

Volumn 154, Issue 4, 2011, Pages 278-285

  Sekerkova A ^a   Polackova M ^b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

Bet v1; Bet v2; Bet v4 specific IgE; Birch pollen; Recombinant allergens

Indexed keywords

BET V1 ANTIGEN; BET V2 ANTIGEN; BET V4 ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; POLLEN ANTIGEN; RECOMBINANT ALLERGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BIRCH; CHILD; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOSENSITIZATION; POLLEN ALLERGY; POLYSENSITIZATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIZATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIGENS, PLANT; BETULA; CALCIUM-BINDING PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFANT; MALE; MIDDLE AGED; PLANT PROTEINS; POLLEN; YOUNG ADULT;

EID: 77958004605     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321819     Document Type: Article

References (31)

1. Simpson CR, Newton J, Hippisley-Cox J, et al: Incidence and prevalence of multiple allergic disorders recorded in a national primary care database. J R Soc Med 2008;101:558-563.
2. D'Amato G, Spieksma FT, Liccardi G, et al: Pollen-related allergy in Europe. Allergy 1998;53:567-578. (Pubitemid 28307924)
3. Movérare R, Westritschnig K, Svensson M, et al: Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Int Arch Allergy Immunol 2002;128:325-335.
4. Rossi RE, Monasterolo G, Monasterolo S: Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v1, Bet v2, Bet v4: evaluation of different IgE reactivity profiles. Allergy 2003;58:929-932. (Pubitemid 37046693)
5. Elfman L, Svensson M, Lidholm J, et al: Different profiles in specific IgE to rBt v 1 end rBet v 2 in patients allergic to birch pollen from six countries. Int Arch Allergy Immunol 1997;113:249-251.
6. Movérare R, Elfman L, Vesterinen E, et al: Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy 2002;57:423-430. (Pubitemid 34442156)
7. Pree I, Reisinger J, Focke M, et al: Analysis of epitope-specific immune responses induced by vaccination with structurally folded, and unfolded recombinant Bet v 1 allergen derivatives in man. J Immunol 2007;179:5309-53016.
8. Purohit A, Niederberger V, Kronqvist M, et al: Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy 2008;38:1514-1525.
9. Mahler V, Vrtala S, Kuss O, et al: Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1. Clin Exp Allergy 2004;34:510-522.
10. Kahlert H, Suck R, Weber B, et al: Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy. Int Arch Allergy Immunol 2008;145:193-206.
11. Cudowska B, Kaczmarski M: Diagnostic value of birch recombinant allergens (rBet v 1, profilin rBet v 2) in children with pollen-related food allergy. Rocz Akad Med Bialymst 2004;49:111-115.
12. Fernández Rivas M: Cross-reactivity between fruit and vegetables. Allergol Immunopathol 2003;31:141-146.
13. Valenta R, Ferreira F, Grote M: Identification of profilin as an actin-binding protein in higher plants. J Biol Chem 1993;268:22777-22781. (Pubitemid 23318338)
14. Engel E, Richter K, Obermeyer G, et al: Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains. J Biol Chem 1997;272:28630-28637.
15. Shirasaki H, Yamamoto T, Koyanagi Y, et al: Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4. Allergol Int 2008;57:93-96.
16. D'Amato G, Cecchi L, Bonini S, et al: Allergenic pollen and pollen allergy in Europe. Allergy 2007;62:976-990. (Pubitemid 47220965)
17. Breitenbach M, Ferreira F, Jilek A, et al: Biological and immunological importance of Bet v 1 iosoforms. Adv Exp Med Biol 1996;409:117-126.
18. Swoboda I, Jilek A, Ferreira F, et al: Isoforms of Bet v 1, the major birch pollen allergen, analyzed by liquid chromatography, mass spectrometry, and cDNA cloning. J Biol Chem 1995;270:2607-2613.
19. Ferreira F, Hirtenlehner K, Jilek A, et al: Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996;183:599-609.
20. Movérare R, Kosunen TU, Haahtela T: Change in the pattern of IgE reactivity to timothy grass and birch pollen allergens over a 20-year period. J Investig Allergol Clin Immunol 2006;16:274-278. (Pubitemid 44580252)
21. Troise C, Voltolini S, Delbono G, et al: Allergy to pollens from Betulacea and Corylaceae in a Mediterranean area (Genoa, Italy): a ten-year retrospective study. J Investig Allergol Clin Immunol 1992;2:313-317.
22. Kazemi-Shirazi L, Niederberger V, Linhart B, et al: Recombinant marker allergens: diagnostic gatekeepers for the treatment of Allergy. Int Arch Allergy Immunol 2002;127:259-268. (Pubitemid 34522813)
23. Asero R: Injection immunotherapy with different airborne allergens did not prevent de novo sensitization to ragweed and birch pollen north of Milan. Int Arch Allergy Immunol 2004;133:49-54.
24. Asero R: Pollen specific immunotherapy is not a risk factor for de novo sensitization to cross-reacting allergens in monosensitized subjects. J Investig Allergol Clin Immunol 2006;16:253-257.
25. Jahn-Schmid B, Radakovics A, Lüttkopf D, et al: Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens. J Allergy Clin Immunol 2005;116:213-219.
26. Ricci G, Righetti F, Menna G, et al: Relationship between Bet v 1 and Bet v 2 specific IgE and food allergy in children with grass pollen respiratoty allergy. Mol Immunol 2005;42:1251-1257.
27. Björkstén B, Dumitrascu D, Foucard T, et al: Prevalence of childhood asthma, rhinitis and eczema in Scandinavia and Eastern Europe. Eur Respir J 1998;12:432-437. (Pubitemid 28389541)
28. Clausen M, Kristjansson S, Haraldsson A, et al: High prevalence of allergic diseases and sensitization in a low allergen country. Acta Paediatr 2008;97:1216-1220.
29. Linneberg A, Jorgensen T, Nielsen NH, et al: The prevalence of skin-test-positive allergic rhinitis in Danish adults: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. Allergy 2000;55:767-772. (Pubitemid 30619495)
30. Linneberg A, Nielsen NH, Madsen F, et al: Secular trends of allergic asthma in Danish adults. Copenhagen Allergy Study. Respir Med 2001;95:258-264.
31. Linneberg AR, Nielsen NH, Madsen FF, et al: Increasing prevalence of specific IgE against aeroallergens in an adult Danish population: two cross-sectional studies in 1990 and 1998. Clin Exp Allergy 2001;31:1409-1417.